misonidazole has been researched along with Animal Mammary Carcinoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, SL; Kang, H; Quarles, CC; Sanchez, V; Sorace, AG; Syed, AK; Yankeelov, TE | 1 |
Cai, S; Chapman, JD; Chen, Y; Finn, R; Gerweck, L; Humm, J; Larson, S; Ling, C; O'Donoghue, J; Ruan, S; Schneider, R; Wen, B; Zanzonico, P | 1 |
Ametamey, S; Honer, M; Jochum, W; Oehler, C; Pruschy, M; Riesterer, O | 1 |
3 other study(ies) available for misonidazole and Animal Mammary Carcinoma
Article | Year |
---|---|
Quantitative [
Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Disease Models, Animal; Female; Fluorescent Antibody Technique; Mammary Neoplasms, Animal; Misonidazole; Nitroimidazoles; Positron-Emission Tomography; Receptor, ErbB-2; Trastuzumab; Tumor Burden; Tumor Hypoxia | 2017 |
Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Female; Fibrosarcoma; Mammary Neoplasms, Animal; Metabolic Clearance Rate; Mice; Mice, Inbred C3H; Misonidazole; Monosaccharides; Nitroimidazoles; Organ Specificity; Tissue Distribution; Tomography, Emission-Computed | 2004 |
Ionizing radiation antagonizes tumor hypoxia induced by antiangiogenic treatment.
Topics: Animals; Carcinoma; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Screening Assays, Antitumor; Glucose Transporter Type 1; Humans; Immunohistochemistry; Mammary Neoplasms, Animal; Mice; Misonidazole; Neoplasm Transplantation; Neovascularization, Pathologic; Phthalazines; Positron-Emission Tomography; Pyridines; Transplantation, Homologous | 2006 |